U.S., April 30 -- An application to own the trademark for 'ONYDA XR' has been filed on May. 29, 2024.
Owner(s):
TRIS PHARMA, INC.; ATTN: General Counsel, 2031 US Highway 130, New Jersey
Goods and/or Services:
For: Pharmaceutical preparations containing clonidine which act on the central nervous system; Pharmaceutical preparations containing clonidine for treatment of attention deficit hyperactivity disorder
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-04-29&serialNumber=98573533
Disclaimer: Curated by HT Syndication....